ReviewJournal of the Royal Society of Medicine1999
The protease-antiprotease battle in the cystic fibrosis lung.
Review in Journal of the Royal Society of Medicine, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Towards better understanding of the heparin role in NETosis: feasibility of using native mass spectrometry to monitor interactions of neutrophil elastase with heparin oligomers.International journal of mass spectrometry · 2021Article
- Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis.Pathogens (Basel, Switzerland) · 2017Review
- Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome.American journal of respiratory cell and molecular biology · 2015Article
- Sirtinol inhibits neutrophil elastase activity and attenuates lipopolysaccharide-mediated acute lung injury in mice.Scientific reports · 2015Article
- Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.Antimicrobial agents and chemotherapy · 2014Article
- Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active.Oral diseases · 2011Article
- Antiproteases as therapeutics to target inflammation in cystic fibrosis.The open respiratory medicine journal · 2010Article
- Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy.Journal of medical microbiology · 2009Article
- Highlights of a workshop to discuss targeting inflammation in cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2009Review
- X-ray snapshot of the mechanism of inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives.Journal of medicinal chemistry · 2008Article
- Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils.Infection and immunity · 2005Article
- Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.Paediatric drugs · 2002Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.